Logo image of MTUS

METALLUS INC (MTUS) Stock Fundamental Analysis

NYSE:MTUS - New York Stock Exchange, Inc. - US8873991033 - Common Stock - Currency: USD

14.24  -0.12 (-0.84%)

Fundamental Rating

3

MTUS gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 154 industry peers in the Metals & Mining industry. While MTUS seems to be doing ok healthwise, there are quite some concerns on its profitability. MTUS is valued correctly, but it does not seem to be growing.


Dividend Valuation Growth Profitability Health

Quickly go to:

2

1. Profitability

1.1 Basic Checks

In the past year MTUS was profitable.
In the past year MTUS has reported a negative cash flow from operations.
Of the past 5 years MTUS 4 years were profitable.
In the past 5 years MTUS always reported a positive cash flow from operatings.
MTUS Yearly Net Income VS EBIT VS OCF VS FCFMTUS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2020 2021 2022 2023 2024 0 50M -50M 100M 150M

1.2 Ratios

MTUS has a Return On Assets (-1.94%) which is comparable to the rest of the industry.
Looking at the Return On Equity, with a value of -3.12%, MTUS is in line with its industry, outperforming 46.75% of the companies in the same industry.
Industry RankSector Rank
ROA -1.94%
ROE -3.12%
ROIC N/A
ROA(3y)4.01%
ROA(5y)4.11%
ROE(3y)6.39%
ROE(5y)6.54%
ROIC(3y)N/A
ROIC(5y)N/A
MTUS Yearly ROA, ROE, ROICMTUS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2020 2021 2022 2023 2024 0 10 -10 20

1.3 Margins

MTUS's Profit Margin has declined in the last couple of years.
MTUS's Operating Margin has declined in the last couple of years.
MTUS's Gross Margin of 6.62% is on the low side compared to the rest of the industry. MTUS is outperformed by 61.04% of its industry peers.
In the last couple of years the Gross Margin of MTUS has declined.
The Profit Margin and Operating Margin are not available for MTUS so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 6.62%
OM growth 3Y-56.4%
OM growth 5YN/A
PM growth 3Y-79.2%
PM growth 5YN/A
GM growth 3Y-19.3%
GM growth 5YN/A
MTUS Yearly Profit, Operating, Gross MarginsMTUS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2020 2021 2022 2023 2024 0 5 -5 10 15

More info and screens

4

2. Health

2.1 Basic Checks

MTUS does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, MTUS has less shares outstanding
Compared to 1 year ago, MTUS has an improved debt to assets ratio.
MTUS Yearly Shares OutstandingMTUS Yearly Shares OutstandingYearly Shares Outstanding 2020 2021 2022 2023 2024 10M 20M 30M 40M
MTUS Yearly Total Debt VS Total AssetsMTUS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

2.2 Solvency

MTUS has an Altman-Z score of 2.01. This is not the best score and indicates that MTUS is in the grey zone with still only limited risk for bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 2.01, MTUS is in line with its industry, outperforming 43.51% of the companies in the same industry.
A Debt/Equity ratio of 0.01 indicates that MTUS is not too dependend on debt financing.
The Debt to Equity ratio of MTUS (0.01) is better than 77.27% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.01
Debt/FCF N/A
Altman-Z 2.01
ROIC/WACCN/A
WACC10.07%
MTUS Yearly LT Debt VS Equity VS FCFMTUS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2020 2021 2022 2023 2024 0 200M 400M 600M

2.3 Liquidity

MTUS has a Current Ratio of 2.03. This indicates that MTUS is financially healthy and has no problem in meeting its short term obligations.
The Current ratio of MTUS (2.03) is comparable to the rest of the industry.
MTUS has a Quick Ratio of 1.21. This is a normal value and indicates that MTUS is financially healthy and should not expect problems in meeting its short term obligations.
MTUS has a Quick ratio of 1.21. This is comparable to the rest of the industry: MTUS outperforms 42.21% of its industry peers.
Industry RankSector Rank
Current Ratio 2.03
Quick Ratio 1.21
MTUS Yearly Current Assets VS Current LiabilitesMTUS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2020 2021 2022 2023 2024 200M 400M 600M

More info and screens

3

3. Growth

3.1 Past

The earnings per share for MTUS have decreased strongly by -97.55% in the last year.
The earnings per share for MTUS have been decreasing by -44.91% on average. This is quite bad
Looking at the last year, MTUS shows a very negative growth in Revenue. The Revenue has decreased by -23.34% in the last year.
The Revenue has been decreasing by -5.46% on average over the past years.
EPS 1Y (TTM)-97.55%
EPS 3Y-44.91%
EPS 5YN/A
EPS Q2Q%-87.5%
Revenue 1Y (TTM)-23.34%
Revenue growth 3Y-5.46%
Revenue growth 5YN/A
Sales Q2Q%-12.78%

3.2 Future

Based on estimates for the next years, MTUS will show a very strong growth in Earnings Per Share. The EPS will grow by 66.92% on average per year.
MTUS is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 7.78% yearly.
EPS Next Y42.3%
EPS Next 2Y66.92%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year6.41%
Revenue Next 2Y7.78%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
MTUS Yearly Revenue VS EstimatesMTUS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 500M 1B 1.5B
MTUS Yearly EPS VS EstimatesMTUS Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 0 1 -1 2 -2 3

More info and screens

4

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 284.80, which means the current valuation is very expensive for MTUS.
MTUS's Price/Earnings ratio is in line with the industry average.
Compared to an average S&P500 Price/Earnings ratio of 26.38, MTUS is valued quite expensively.
MTUS is valuated reasonably with a Price/Forward Earnings ratio of 9.46.
Based on the Price/Forward Earnings ratio, MTUS is valued a bit cheaper than the industry average as 77.27% of the companies are valued more expensively.
MTUS is valuated cheaply when we compare the Price/Forward Earnings ratio to 22.13, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 284.8
Fwd PE 9.46
MTUS Price Earnings VS Forward Price EarningsMTUS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 50 100 150 200 250

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, MTUS is valued a bit cheaper than 61.04% of the companies in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 11.92
MTUS Per share dataMTUS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 10 15 20

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates MTUS does not grow enough to justify the current Price/Earnings ratio.
A more expensive valuation may be justified as MTUS's earnings are expected to grow with 66.92% in the coming years.
PEG (NY)6.73
PEG (5Y)N/A
EPS Next 2Y66.92%
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

No dividends for MTUS!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

METALLUS INC

NYSE:MTUS (6/5/2025, 3:36:08 PM)

14.24

-0.12 (-0.84%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryMetals & Mining
Earnings (Last)05-08 2025-05-08/amc
Earnings (Next)08-06 2025-08-06/amc
Inst Owners83.43%
Inst Owner ChangeN/A
Ins Owners3.26%
Ins Owner Change4.84%
Market Cap598.36M
Analysts43.33
Price Target20.4 (43.26%)
Short Float %6.21%
Short Ratio5.74
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-1249.83%
Min EPS beat(2)-2455.3%
Max EPS beat(2)-44.35%
EPS beat(4)0
Avg EPS beat(4)-682.68%
Min EPS beat(4)-2455.3%
Max EPS beat(4)-44.35%
EPS beat(8)3
Avg EPS beat(8)-331.48%
EPS beat(12)4
Avg EPS beat(12)-219.89%
EPS beat(16)8
Avg EPS beat(16)-155.64%
Revenue beat(2)1
Avg Revenue beat(2)0.87%
Min Revenue beat(2)-2.41%
Max Revenue beat(2)4.16%
Revenue beat(4)1
Avg Revenue beat(4)-7.99%
Min Revenue beat(4)-25.39%
Max Revenue beat(4)4.16%
Revenue beat(8)1
Avg Revenue beat(8)-4.95%
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)1.69%
EPS NQ rev (3m)-23.08%
EPS NY rev (1m)-5.44%
EPS NY rev (3m)-30.03%
Revenue NQ rev (1m)0.62%
Revenue NQ rev (3m)-3.98%
Revenue NY rev (1m)-0.42%
Revenue NY rev (3m)-2%
Valuation
Industry RankSector Rank
PE 284.8
Fwd PE 9.46
P/S 0.57
P/FCF N/A
P/OCF N/A
P/B 0.87
P/tB 0.88
EV/EBITDA 11.92
EPS(TTM)0.05
EY0.35%
EPS(NY)1.5
Fwd EY10.57%
FCF(TTM)-2.53
FCFYN/A
OCF(TTM)-0.76
OCFYN/A
SpS24.82
BVpS16.33
TBVpS16.25
PEG (NY)6.73
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -1.94%
ROE -3.12%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 6.62%
FCFM N/A
ROA(3y)4.01%
ROA(5y)4.11%
ROE(3y)6.39%
ROE(5y)6.54%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)6.03%
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3Y-56.4%
OM growth 5YN/A
PM growth 3Y-79.2%
PM growth 5YN/A
GM growth 3Y-19.3%
GM growth 5YN/A
F-Score2
Asset Turnover0.95
Health
Industry RankSector Rank
Debt/Equity 0.01
Debt/FCF N/A
Debt/EBITDA 0.15
Cap/Depr 136.76%
Cap/Sales 7.13%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 2.03
Quick Ratio 1.21
Altman-Z 2.01
F-Score2
WACC10.07%
ROIC/WACCN/A
Cap/Depr(3y)85.34%
Cap/Depr(5y)59.9%
Cap/Sales(3y)3.92%
Cap/Sales(5y)2.95%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-97.55%
EPS 3Y-44.91%
EPS 5YN/A
EPS Q2Q%-87.5%
EPS Next Y42.3%
EPS Next 2Y66.92%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-23.34%
Revenue growth 3Y-5.46%
Revenue growth 5YN/A
Sales Q2Q%-12.78%
Revenue Next Year6.41%
Revenue Next 2Y7.78%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-117.34%
EBIT growth 3Y-58.78%
EBIT growth 5YN/A
EBIT Next Year254.17%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-132.56%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-67.84%
OCF growth 3Y-41.07%
OCF growth 5YN/A